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PURPOSE. To investigate the association between the microstructure of b-zone parapapillary
atrophy (bPPA) and parapapillary deep-layer microvasculature dropout assessed by optical
coherence tomography angiography (OCT-A).
METHODS. Thirty-seven eyes with bPPA devoid of the Bruch’s membrane (BM) (cPPA) ranging
between completely absent and discontinuous BM were matched by severity of the visual
field (VF) damage with 37 eyes with fully intact BM (bPPAþBM) based on the spectral-domain
(SD) OCT imaging. Parapapillary deep-layer microvasculature dropout was defined as a
dropout of the microvasculature within choroid or scleral flange in the bPPA on the OCT-A.
The widths of bPPA, cPPA, and bPPAþBM were measured on six radial SD-OCT images.
Prevalence of the dropout was compared between eyes with and without cPPA. Logistic
regression was performed for evaluating association of the dropout with the width of bPPA,
cPPA, and bPPAþBM, and the cPPA presence.
RESULTS. Eyes with cPPA had significantly higher prevalence of the dropout than did those
without cPPA (75.7% versus 40.8%; P ¼ 0.004). In logistic regression, presence and longer
width of the cPPA, worse VF mean deviation, and presence of focal lamina cribrosa defects
were significantly associated with the dropout (P < 0.05), whereas width of the bPPA and
bPPAþBM, axial length, and choroidal thickness were not (P > 0.10).
CONCLUSIONS. Parapapillary deep-layer microvasculature dropout was associated with the
presence and larger width of cPPA, but not with the bPPAþBM width. Presence and width of
the exposed scleral flange, rather than the retinal pigmented epithelium atrophy, may be
associated with deep-layer microvasculature dropout.
Keywords: deep-layer microvasculature dropout, parapapillary atrophy, optical coherence
tomography angiography
b -Zone parapapillary atrophy (bPPA), a feature of theglaucomatous eye,1 is characterized by atrophy of the
retinal pigment epithelium (RPE) and choriocapillaris adjacent
to the optic disc.1–3 It has been suggested that reduced blood
supply to the optic nerve head (ONH) due to closure of the
choriocapillaris may be a mechanism that accounts for the
relationship between the bPPA and glaucoma.1–5 Specifically,
characteristics of the deep-layer microvasculature contained
within the bPPA may differ according to whether Bruch’s
membrane (BM) is present (bPPAþBM), or discontinuous or
absent (c-zone PPA [cPPA]).3,6–12 In cPPA areas devoid of the
BM, parapapillary deep-layer microvasculature is composed of
the microvasculature located within the elongated scleral
flange.3,12 In contrast, in bPPAþBM areas, deep-layer microvas-
culature is only composed of the choriocapillaris.6,12 However,
little is known about this issue since noninvasive visualization
of the deep-layer microvasculature has not been possible until
the recent development of optical coherence tomography
angiography (OCT-A). OCT-A enables visualization of both deep-
layer and superficial microvasculature.6,12–17
The objective of the present study is to elucidate the
association between the microstructure of the bPPA and the
deep-layer microvasculature dropout in primary open-angle
glaucoma (POAG) patients.
MATERIALS AND METHODS
POAG patients were included from the Diagnostic Innovations
in Glaucoma Study (DIGS) (ClinicalTrials.gov identifier:
NCT00221897).12,15,16,18 Details of the DIGS protocol and
eligibility have been described previously.18 This study was
approved by the institutional review boards at the University of
California, San Diego, and conformed to the tenets of the
Declaration of Helsinki and the Health Insurance Portability and
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Accountability Act. Informed consent was obtained from all
participants.12
Study Subjects
Established POAG patients who had good-quality OCT-A images
(Angiovue; Optovue, Inc., Fremont, CA, USA) and radial ONH
images using both spectral-domain OCT (SD-OCT) (Spectralis;
Heidelberg Engineering GmbH, Heidelberg, Germany) and
swept-source OCT (SS-OCT) images (DRI-OCT; Topcon, Tokyo,
Japan) were enrolled. All subjects completed an ophthalmo-
logic examination, including assessment of best corrected
visual acuity, refractive error, slit-lamp biomicroscopy, intraoc-
ular pressure (IOP) measurement with Goldmann applanation
tonometry, gonioscopy, central corneal thickness (CCT)
measured with ultrasound pachymetry (DGH Technology
Inc., Exton, PA, USA), axial length measured by the IOL Master
(Carl Zeiss Meditec, Dublin, CA, USA), dilated fundus
examination, simultaneous stereophotography of the optic
disc, standard automated perimetry (Humphrey Field Analyzer,
24-2 Swedish interactive threshold algorithm; Carl Zeiss
Meditec), SD-OCT, OCT-A, and SS-OCT. Perimetry and all
imaging tests were conducted within a 6-month period.12
Systolic and diastolic blood pressure (BP) was measured at the
height of the heart with an Omron Automatic BP instrument
(Model BP791IT; Omron Healthcare, Inc., Lake Forest, IL,
USA). Mean ocular perfusion pressure (MOPP) was calculated
according to the following formula: MOPP ¼ 2 =3 (mean arterial
pressure IOP), where mean arterial pressure (MAP) = DBPþ
1 =
3 (SBPDBP). Presence of an optic disc hemorrhage (DH) was
defined as an isolated splinter or flame-shaped hemorrhage on
the ONH based on standardized review of annually acquired
optic disc stereophotographs.12
To be included in the current study, POAG patients were
required to have visible bPPA on fundus imaging with a
temporal width ‡100 lm on at least one radial scan measured
by the built-in caliper of the SD-OCT, BVCA ‡20/40, and open
angles by gonioscopy.12 Subjects with a history of ocular
intervention (except for uncomplicated cataract or glaucoma
surgery), intraocular diseases (e.g., diabetic retinopathy or
nonglaucomatous optic neuropathy), or systemic diseases
(e.g., stroke or pituitary tumor) that could influence the study
results were excluded. Those with systemic hypertension (HT)
and diabetes mellitus (DM) were included unless they were
diagnosed to have diabetic or hypertensive retinopathy.
Subjects with unreliable visual field (VF) or poor-quality
imaging tests were also excluded.12
POAG was defined as the presence of glaucomatous optic
nerve damage (i.e., the presence of focal thinning, notching,
localized or diffuse atrophy of retinal nerve fiber layer) and
compatible repeated VF damage. Glaucomatous VF damage
was defined as a VF outside normal limits on Glaucoma
Hemifield Test or pattern standard deviation (PSD) outside 95%
normal limits confirmed on two consecutive, reliable (20%
fixation losses, 15% false positives and false negatives) tests.12
SD-OCT Imaging of b-Zone Parapapillary Area
Spectralis SD-OCT software (Glaucoma Module Premium
Edition, version 1.7.0.0; Heidelberg Engineering GmbH) was
used to visualize the ONH, including the PPA area, using a 939-
mm-sized rectangle centered on the ONH (Fig. 1A1, B1).
Details were described elsewhere.19,20 Briefly, 24 consecutive
radial equidistant B-scans were acquired. Each B-scan, sub-
tending 158, starting from the fovea-BM opening (BMO) axis
was automatically determined by the device. From the 24 radial
scans, six good-quality radial scans (quality score > 15)
extending equidistant from the fovea-BMO axis were selected
and included in the analysis (Fig. 1A1).8
Analysis of b-Zone Parapapillary Atrophy
The PPA region was evaluated using the Spectralis software
feature that facilitated synchronous viewing of the color-
converted infrared fundus image and the selected location on
the OCT scan.6–8 The presence of the bPPA was defined as an
area without the RPE. cPPA was defined as an area with the
exposed Elschnig’s ring between the optic disc boundary and
the BM tips. Both bPPA and cPPA were required to have a
temporal width ‡100 lm on at least one radial OCT scan image
as measured by the built-in caliper of the Spectralis OCT (Fig.
1A1, B1).8,9 The presence of bPPA and cPPA was determined
independently by two experienced observers (MHS and PICM)
who were masked to patients’ clinical information.8,9 Dis-
agreements were resolved by consensus between the two
observers. If consensus could not be reached, the subject was
excluded from the analysis.
Eyes with bPPA were divided into two groups according to
the presence of cPPA (eyes with and without cPPA). The two
groups were matched for the VF mean deviation (MD) to
minimize the influence of glaucoma severity on the deep-layer
microvasculature dropout.12,21 Specifically, patients with cPPA
were matched to patients without cPPA into three groups
based on the severity of their VF damage, (18 early POAG [MD
> 6 dB], 12 moderate POAG [12 dB  MD  6 dB], and
seven advanced POAG [MD < 12 dB]) by using a frequency-
matching method. For specific analyses, eyes with cPPA were
further classified into two subgroups: (1) those with discon-
tinuous BM (PPA with some BM present) and (2) those lacking
BM (PPA in which BM was absent throughout the entire
area).6,8–10 In addition, focal cPPA was defined as cPPA
localized to the superior or inferior hemiretina and not
involving the fovea-BMO axis (Fig. 1A1).
The bPPA and cPPA width were measured by the two
observers (MHS and PICM) as the distance between the
temporal optic disc boundary and the temporal margin of the
RPE and BM tips, respectively, using the built-in caliper tool of
the Spectralis SD-OCT. The average of bPPA and cPPA width
measured by the two observers at six radial scans, for which
the center was located at the fovea-BMO axis, was calculated
(Fig. 1A1, B1).8 If the temporal margin of the ONH or bPPA was
not well visualized, adjacent radial scans 158 apart were used
for the measurement. bPPAþBM width was calculated as the
difference between the bPPA and cPPA width.
OCT-A Imaging
The Angiovue incorporated in the Avanti SD-OCT system
provides noninvasive visualization of the vasculature of various
user-defined retinal layers by using the motion contrast
technique and split-spectrum amplitude-decorrelation angiog-
raphy method. Details have been described in else-
where.12,13,15–17,22–24 Based on the quality review according
to a standard protocol established by the Imaging Data
Evaluation and Analysis (IDEA) Reading Center, OCT-A images
with poor image quality, as defined by the following criteria,
were excluded: (1) a signal strength index <48 (1¼minimum,
100¼maximum), (2) poor clarity, (3) residual motion artifacts
visible as irregular vessel pattern or disc boundary on the
enface angiogram, (4) local weak signal, (5) segmentation
errors of the retinal nerve fiber layer (RNFL) and choroidal
layer. The delineation of disc margin was reviewed for accuracy
and adjusted manually as necessary according to standard
protocols.12 Vessel density (%) of the microvasculature located
in the RNFL was calculated as the proportion of measured area
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occupied by flowing blood vessels on the ONH 4.5 3 4.5-mm
field of view images centered on the optic disc.12,15,16
Circumpapillary vessel density (cpVD) was calculated in a
region defined as a 750-lm-wide elliptical annulus extending
from the optic disc boundary based on 3608 global area.12,15,16
Dropout of the Deep-Layer Microvasculature in the
Parapapillary Atrophy
Details for determining the presence of deep-layer microvas-
culature dropout within the bPPA is described elsewhere.12
Briefly, two independent observers (MHS and PICM) masked to
the patients’ baseline characteristics and optic disc features
qualitatively analyzed the bPPA area on 4.5 3 4.5-mm-sized
choroidal layer vessel density map and the infrared fundus
images acquired at the same positions. Discrepancies between
the two observers were resolved by consensus, or if consensus
could not be reached, the subject was excluded from the
analysis.12 A parapapillary deep-layer microvasculature drop-
out was defined as a complete loss of the choriocapillaris or
the microvasculature within the scleral flange on both
horizontal and enface choroidal layer vessel density maps
(Fig. 1A2).12 To avoid false positives, dropout was required to
be present in at least four consecutive horizontal scans and also
to be ‡200 lm in diameter on at least one scan.12 To avoid
false negatives, reflectance or shadowing of the large vessels
on the horizontal and en face images were excluded from the
qualitative review.12 For determining the presence of deep-
layer microvasculature dropout within the cPPA in eyes with
both dropout and cPPA, Spectralis SD-OCT and OCT-A images
were aligned by registering images to large vessels (Fig. 1A1,
A2).
SS-OCT Imaging
The optic disc was imaged with the Topcon DRI SS-OCT device
to determine the presence of focal lamina cribrosa (LC) defects
and to measure choroidal thickness. Details have been
described elsewhere.12,25–27 Both en face and horizontal SS-
OCT images covering a 12 3 9-mm cube centered on the
posterior pole were obtained using a three-dimensional raster
scan (wide-field protocol) consisting of 256 serial horizontal B-
scans.12,25–27
Poor-quality images with motion artifacts, quality score
<50, clipped or poorly focused scans, poorly visible LC, or the
segmentation failure of the choroidal layer were exclud-
ed.12,25–27 Poor visibility of the LC was defined as <70%
visibility of the anterior laminar surface within the BM
opening12,16 and segmentation failure of choroid as >25%
discordance between the visual inspection and the automated
identification of the BM and the chorioscleral interface.12,25,26
Based on the horizontal and enface SS-OCT images,
presence of focal LC defects was determined as laminar holes
or laminar disinsertions violating the normal U- or W-shaped
contour of the anterior laminar surface by the two observers
(MHS and PICM) masked to the patients’ clinical informa-
tion.12,16,28–34 The subject was excluded from the analysis if
consensus between the two observers could not be reached.
To be classified as a LC defect, the size of the focal LC defect
was required to be ‡100 lm in diameter and >30 lm in depth
in at least two consecutive scans.12,16,28–32 These criteria were
FIGURE 1. OCT-A–derived deep-layer microvasculature dropout according to the microstructure of bPPA. (A) Right eye of 70-year-old POAG patient
with bPPA devoid of the BM (cPPA) and (B) right eye of 87-year-old POAG patient with bPPA with bPPAþBM, but without cPPA. (A1, B1) Right images
are B-scans obtained at locations indicated by a white vertical arrow of the color-converted fundus images. Six radial B-scans (white arrows) of the
SD-OCT centered on the fovea-BM opening (BMO) axis (white horizontal arrow) were selected, and temporal margins of the bPPAþBM indicating
RPE tips (red dots and black arrowheads), cPPA indicating BM termination (sky blue dots and blue arrows), and optic disc (white arrowheads)
were delineated. Note that inferior localized cPPA not involving the fovea-BMO axis was present in (A1), while bPPAþBM with intact BM occupied
the entire bPPA area in (B1). (A2, B2) En face (upper) and horizontal (lower) B-scans of choroidal layer vessel density maps of the OCT-A. Green
solid lines indicate locations of B-scans. Well demarcated deep-layer microvasculature dropout (yellow arrowheads) within the cPPA was observed
in (A2), whereas deep-layer microvasculature was relatively preserved (green arrowheads) in (B2). (A3) The two eyes did not show notable
difference in the degree of VF damage.
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used to reduce the possibility that the LC defects were
identified due to the hyporeflective vascular shadowing on the
en face SS-OCT images and the disc photographs.12,16,34
Total choroidal thickness was derived from the average
choroidal thickness values from each of 108 locations from a 1-
mm2-sized grid on the 12 3 9-mm wide-field SS-OCT images
using standard SS-OCT software.12,26
Data Analysis
Clinical characteristics, ONH morphologic parameters, and
OCT-A–derived parameters were compared between eyes
with and without cPPA. For continuous variables, Student’s t-
test and Mann-Whitney U test were used, depending on the
normality test results. For categorical variables, the v2 test
was performed.12 Univariable and multivariable logistic
regression analyses were performed to determine the
association between the parapapillary deep-layer microvascu-
lature dropout and the bPPA microstructure. Variables with a
P value of <0.10 in the univariable analyses were included in
the multivariable logistic regression to adjust potential
confounding factors in evaluating association between the
deep-layer microvasculature dropout and bPPA microstruc-
ture. Interobserver agreement in determining the presence of
the bPPA and cPPA, microvasculature dropout, and focal LC
defects were assessed using the j coefficient.35,36 Interob-
server agreement in measuring the bPPA and cPPA width was
assessed using Bland-Altman analysis. Statistical software
(MedCalc; Med-Calc, Inc., Mariakerke, Belgium) was used
for statistical analyses, and the a level (type I error) was set at
0.05.
RESULTS
Study Population
One hundred forty eyes of 140 consecutive POAG DIGS
patients who were evaluated for eligibility were included in
this report. Of these 140 eyes, 27 were excluded for the
following reasons: (1) poor-quality SD-OCT images (n¼ 9), (2)
an absence of bPPA (n ¼ 11), and (3) temporal bPPA width
<100 mm (n ¼ 7). Among the remaining 113 eyes of 113
patients, 11 eyes were excluded due to poor OCT-A, nine eyes
due to poor SS-OCT images, and one eye due to failure to reach
the consensus between observers for the determination of the
deep-layer microvasculature dropout. A final sample of 92 eyes
was available for analysis; from this sample, 37 eyes with cPPA
were matched for severity of VF damage by the frequency-
matching method with 37 eyes without cPPA. Six of 37 eyes
(16.2%) had cPPA lacking BM, whereas the remaining 31 eyes
(83.8%) had discontinuous BM.
Clinical characteristics and presence of the deep-layer
microvasculature dropout of the POAG patients (37 with and
37 without cPPA) were compared (Table 1). Eyes with and
without cPPA were not significantly different with respect to
sex; CCT; ethnicity; presence of diabetes and systemic
hypertension; antihypertensive and diabetes medication; num-
ber of glaucoma medications; IOP; systolic and diastolic BP
MOPP; presence of the DH, VF MD, VF PSD; presence of the
focal LC defect; and total choroidal thickness (all P > 0.10).
Eyes with cPPA were more myopic and had longer axial lengths
than those without cPPA (2.4 6 2.5 vs. 0.5 6 1.6 diopter
[D] for spherical equivalent and 25.2 6 1.4 vs. 24.0 6 1.0 mm
for axial length; P < 0.05). Subjects who had eyes with cPPA
were younger than those without cPPA with marginal
significance (70.0 6 10.9 vs. 74.8 6 11.9 years; P ¼ 0.073).
Upper nasal and inferonasal cpVD were significantly higher
(54.1% 6 6.1% versus 50.2% 6 9.3% for upper nasal cpVD and
55.4% 6 10.1% versus 50.2% 6 9.3% for inferonasal cpVD; P <
0.05) in eyes with cPPA compared to eyes without cPPA. For all
other RNFL and cpVD variables, the two groups were not
different (all P > 0.10).
Interobserver Agreement for the Measurement
Interobserver agreement for determining the cPPA, cPPA with
discontinuous BM, focal cPPA, deep-layer microvasculature
dropout, and focal LC defect were excellent (j ¼ 0.86, 95%
confidence interval [CI] 0.75–0.98, P < 0.001 for cPPA; j ¼
0.89, 95% CI 0.69–1.00, P < 0.001 for cPPA with discontin-
uous BM; j¼0.87, 95% CI 0.63–1.00, P< 0.001 for focal cPPA;
j ¼ 0.86, 95% CI 0.74–0.98, P < 0.001 for dropout; and j ¼
0.82, 95% CI 0.70–0.94, P< 0.001 for focal LC defect).36 Based
on the Bland-Altman plot, there was good agreement between
the two observers in the bPPA and cPPA width as follows: the
mean differences between the two observers were 21.5 lm
(95% CI, 4.4–38.6 lm) for bPPA width and 42.3 lm (95% CI,
21.2–63.4 lm) for cPPA width, respectively; the 95% CI of the
limits of agreement for bPPA width was 123.3 to 166.3 lm
(95% CI of the upper limits, 136.9–195.6 lm; lower limits,
152.6 to93.9 lm), and for cPPA width was81.6 to 166.2
lm (95% CI of the upper limits, 129.9–202.6 lm; lower limits,
118.0 to45.3 lm) (Fig. 2).
Deep-Layer Microvasculature Dropout and ONH
Morphologic Parameters in Eyes With and Without
cPPA
The ONH morphologic parameters measured by Spectralis SD-
OCT and presence of the parapapillary deep-layer microvascu-
lature dropout were compared between eyes with and without
cPPA (Table 2). Eyes with cPPA had a significantly higher
prevalence of the deep-layer microvasculature dropout (75.7%
versus 40.8%; P¼ 0.004), larger bPPA width (411.4 6 211.5 vs.
277.4 6 97.8 lm; P < 0.001), and smaller bPPAþBM width
(180.3 6 120.1 vs. 277.4 6 97.8 lm; P < 0.001). The two
groups were not significantly different with respect to the
BMO area (P¼0.947) and fovea-BMO angle (P¼0.900). Among
28 eyes with both cPPA and deep-layer microvasculature
dropout, 26 eyes (92.9%) had cPPA areas containing dropouts
(Fig. 1A1).
bPPA Microstructure and Deep-Layer
Microvasculature Dropout
Univariable and multivariable logistic regression analyses
were used to evaluate the association between the width of
bPPA, cPPA, and bPPAþBM and presence of the cPPA and
parapapillary deep-layer microvasculature dropout (Tables
3–6).
In the univariable analysis (Table 3), parapapillary deep-
layer microvasculature dropout was significantly associated
with the longer bPPA width (odds ratio [OR], 1.01; P ¼
0.0008), cPPA presence (OR, 4.08; P ¼ 0.004), longer cPPA
width (OR, 1.01; P ¼ 0.0052), lower cpVD (OR, 1.16; P <
0.001), worse VF MD (OR, 1.24; P < 0.001), presence of the
focal LC defect (OR, 3.18; P¼ 0.017), thinner total choroidal
thickness (OR, 1.01; P¼ 0.025), and longer axial length (OR,
1.49; P ¼ 0.036). Age; sex; race; CCT; IOP; systolic and
diastolic BP; MOPP; prevalence of the DM, HT, and DH; BMO
opening area; fovea-BMO angle; and bPPAþBM width were not
significantly associated with microvasculature dropout (all P>
0.10).
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In order to avoid issues of multicollinearity in the
multivariable analysis, we evaluated the correlations between
covariates. We found that VF MD, cpVD, and presence of the
focal LC defects were significantly associated with one another.
For this reason, the correlated variables were included in the
multivariable model separately to avoid issues of multicolli-
nearity.
cPPA Presence and Deep-Layer Microvasculature
Dropout
Multivariable logistic regression analysis demonstrated that
cPPA presence remained as a significant factor associated with
the presence of dropout after adjusting for axial length, total
choroidal thickness, and VF MD (OR, 5.34; P ¼ 0.012) (Table
TABLE 1. Comparison of the Demographics and Test Results Between POAG Patients According to the Presence of the bPPA Devoid of the BM
(cPPA)
Variables
Eyes With cPPA, 37 Eyes,
37 Patients
Eyes Without cPPA, 37 Eyes,
37 Patients P Value
Age, y 70.0 6 10.9 74.8 6 11.9 0.073*
Sex, male/female 18/19 20/17 0.816†
Spherical equivalent, D 2.4 6 2.5 0.5 6 1.6 <0.001*
Axial length, mm 25.2 6 1.3 24.0 6 1.0 <0.001*
CCT, lm 534.8 6 55.4 530.7 6 40.9 0.720*
Ethnicity, Asian/European/African descent 6/28/3 4/24/9 0.157†
Self-reported history of diabetes, n (%) 0 (0) 4 (10.8) 0.123†
Self-reported history of hypertension, n (%) 12 (32.4) 18 (48.6) 0.163†
Antihypertensive medication, n (%) 10 (27.0) 14 (37.8) 0.456†
Diabetes medication, n (%) 0 (0) 3 (8.1) 0.239†
Topical glaucoma medications, n 0.225†
0 8 14
1 17 16
>1 12 7
Topical medications, n 0.360†
Prostaglandin analogues 23 20
b-antagonists 10 3
Carbonic anhydrase inhibitors 10 4
a-1 agonist 6 5
IOP, mm Hg 14.5 6 4.5 13.3 6 5.0 0.179‡
Systolic BP, mm Hg 122.0 6 15.0 130.2 6 12.5 0.027‡
Diastolic BP, mm Hg 75.9 6 9.8 77.4 6 11.2 0.546*
MOPP, mm Hg 61.5 6 13.1 59.6 6 11.2 0.499‡
DH, n (%) 9 (24.3) 3 (8.1) 0.115†
VF MD, dB 7.47 6 5.97 7.92 6 7.00 0.974‡
VF PSD, dB 7.95 6 4.23 6.45 6 4.02 0.144‡
cpRNFL thickness, lm
Global area 69.8 6 11.0 69.3 6 11.6 0.828*
Upper temporal 58.4 6 15.6 57.3 6 13.4 0.746*
Upper nasal 64.3 6 11.3 60.3 6 13.4 0.164*
Lower nasal 59.1 6 9.9 57.0 6 10.3 0.380*
Lower temporal 51.3 6 11.7 53.4 6 9.4 0.393*
Superotemporal 93.4 6 22.7 88.8 6 18.4 0.341*
Superonasal 82.7 6 16.9 77.2 6 17.2 0.167*
Inferonasal 75.1 6 17.5 77.7 6 20.9 0.566*
Inferotemporal 74.7 6 23.3 82.5 6 24.0 0.163*
Whole-image vessel density, % 46.5 6 5.3 45.0 6 5.5 0.226*
Circumpapillary vessel density, %
Global area 54.0 6 6.2 53.0 6 6.6 0.514*
Upper temporal 58.8 6 9.7 58.1 6 8.3 0.556‡
Upper nasal 54.1 6 6.1 50.2 6 9.3 0.013*
Lower nasal 52.1 6 6.7 51.6 6 7.4 0.756*
Lower temporal 55.9 6 8.4 55.5 6 7.2 0.810*
Superotemporal 55.6 6 9.6 53.6 6 8.8 0.365*
Superonasal 54.8 6 6.1 52.3 6 7.3 0.107*
Inferonasal 55.4 6 10.1 50.2 6 9.3 0.024*
Inferotemporal 48.6 6 10.5 52.4 6 11.1 0.133*
Focal LC defect, n (%) 18 (48.6) 19 (51.4) 0.829*
Total choroidal thickness, lm 137.1 6 45.9 159.9 6 64.7 0.158‡
Values are shown in mean 6 standard deviation. Statistically significant values are shown in bold. D, diopter; cpRNFL, circumpapillary retinal
nerve fiber layer.
* The comparison was performed using independent samples t-test.
† The comparison was performed using v2 test.
‡ The comparison was performed using Mann-Whitney U test.
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4). Similarly, cPPA presence remained as a significant factor
associated with deep-layer microvasculature dropout in models
when focal LC defects (OR, 3.75; P ¼ 0.030) and cpVD (OR,
5.67; P ¼ 0.009) each were included in the multivariable
models instead of VF MD (Table 4).
cPPA Width and Deep-Layer Microvasculature
Dropout
Longer cPPA width also remained as a significant factor
associated with deep-layer microvasculature dropout after
adjusting axial length, total choroidal thickness, and VF MD
(OR, 1.01; P¼ 0.039) (Table 5). Similar patterns were observed
in the multivariable analysis when cpVD was included instead
of VF MD (OR, 1.01; P ¼ 0.048). When focal LC defect was
included instead of VF MD, cPPA width was marginally
significant (OR, 1.01; P ¼ 0.073) (Table 5).
Focal cPPA and Deep-Layer Microvasculature
Dropout
Five of 37 eyes (13.5%) with cPPA had focal cPPA not involving
the fovea-BMO axis, and all of them had deep-layer microvas-
culature dropout located within the cPPA region (Fig. 1A1).
Eyes with focal cPPA had significantly shorter axial length than
the remaining 32 eyes with cPPA involving the fovea-BMO axis
(23.7 6 0.80 vs. 25.5 6 1.3 mm, P ¼ 0.005; independent t-
test).
bPPA Width and Deep-Layer Microvasculature
Dropout
bPPA width was not significantly associated with the deep-layer
microvasculature dropout after adjusting for axial length, total
choroidal thickness, and VF MD (P ¼ 0.176) (Table 6). Similar
patterns were observed in the multivariable analysis when
focal LC defect (P ¼ 0.112) and cpVD (P ¼ 0.166) were
included instead of VF MD (Table 6). In all multivariable logistic
regression analyses, worse VF MD was significantly associated
with the deep-layer microvasculature dropout (all P < 0.05),
while axial length and total choroidal thickness were not
significantly associated with the dropout (all P > 0.10) (Tables
4–6).
DISCUSSION
This study found that glaucomatous eyes with cPPA had a
significantly higher prevalence of parapapillary deep-layer
microvasculature dropout than those with bPPAþBM (75.7%
versus 40.8%, P ¼ 0.004; v2 test). Furthermore, parapapillary
deep-layer microvasculature dropout was positively associated
with the presence and longer width of the cPPA even after
adjusting for other potentially confounding factors such as
axial length, choroidal thickness, glaucoma severity, and
presence of focal LC defects.12 However, width of the bPPAþBM
was not associated with deep-layer microvasculature dropout.
These findings suggest that parapapillary deep-layer microvas-
culature dropout may be associated with a continuum of cPPA
with exposed scleral flange ranging from completely present to
completely absent but not with the area of bPPAþBM with
atrophic change of the RPE.
Our previous study12 showed that deep-layer microvascu-
lature dropout within the bPPA was associated with more
advanced disease status, presence of a focal LC defect, reduced
superficial microvasculature, thinner choroidal thickness, and
lower diastolic BP. However, in the previous study, the
association between the dropout and microstructure of bPPA
was not evaluated.12 The current study demonstrated that
cPPA area was significantly associated with the presence of
deep-layer microvasculature dropout. These results are consis-
FIGURE 2. Bland-Altman plots showing the width of bPPA (A) and cPPA (B) of the two observers. The solid lines represent the mean difference, and
the dashed lines represent the 95% limits of agreement (LOA).
TABLE 2. Comparison of the ONH Morphologic Parameters Measured
by Spectralis SD-OCT and Presence of the Parapapillary Deep-Layer
Microvasculature Dropout Measured by OCT-A Between Eyes With and
Without cPPA According to the Presence of the bPPA Devoid of the BM
Variables
Eyes
With cPPA,
37 Eyes,
37 Patients
Eyes
Without cPPA,
37 Eyes,
37 Patients
P
Value
BMO area, mm2 2.1 6 0.6 2.1 6 0.5 0.947*
Fovea-BMO angle, deg 7.6 6 3.9 7.7 6 4.6 0.900*
bPPA width, lm 411.4 6 211.5 277.4 6 97.8 <0.001†
bPPAþBM width, lm 180.3 6 120.1 277.4 6 97.8 <0.001†
Presence of the deep-
layer microvasculature
dropout, %
28 (75.7) 15 (40.8) 0.004‡
* The comparison was performed by using independent samples t-
test.
† The comparison was performed by using Mann-Whitney U test.
‡ The comparison was performed by using v2 test.
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tent with previous studies suggesting that penetrating branch-
es of the short posterior ciliary artery passing through the
scleral flange may be subject to increased mechanical stress
and strain.37,38 Therefore, cPPA with exposed scleral flange
may be a sign of increased IOP-related scleral tension that leads
to disruption of the deep-layer microvasculature. Further
measurement of the IOP-related stress or strain and subsequent
vascular changes according to the presence and continuum of
the exposed scleral flange are warranted to elucidate this
speculation.
However, how the relationship between the cPPA and
parapapillary deep-layer microvasculature dropout relates to
the pathophysiology of glaucoma is still unclear. The current
results do not concur with other studies suggesting that the
presence and width of the cPPA may be associated with slower
progression of glaucoma9,10 and with studies suggesting that
deep-layer microvasculature dropout is associated with a more
advanced disease status.11,12 Also, the presence and width of
the cPPA is known to be associated with axial elongation of the
eye globe.6,7 Therefore, as axial globe elongation is halted with
aging, the mechanical stress due to scleral stretching may also
be relieved. Possible explanations for the discrepancies among
studies may be attributed to differences of the study
population and definition regarding the microstructure of the
PPA.6,7 In the current study, glaucomatous eyes with cPPA had
significantly longer axial lengths, larger bPPA width, and
smaller BMO area than those without cPPA. In a univariable
regression for determining factors associated with the deep-
layer microvasculature dropout, axial length and bPPA width
remained as associated factors as well as the presence and
width of cPPA. However, in multivariable regression, only the
width and presence of the cPPA were significantly associated
with deep-layer microvasculature dropout; axial length and
bPPA width, therefore, were excluded in most models. One
possible explanation for these results is a relatively small
number of eyes with high myopia (axial length ‡ 26.5 mm or
spherical equivalent ‡6.0 D) (n¼ 7) and older patients with
cPPA (72.4 years) than those of previous studies (age ranging
between 42.9 and 58.9 years).6,9,10 Therefore, there were
proportionately fewer cPPA eyes that completely lacked BM
(16.2%, n ¼ 6) than in previous studies (percentage of cPPA
completely lacking BM ranging between 18.8% and
35.6%).6,9,10 Second, a pathogenic process other than axial
elongation may contribute to the development of a certain type
of bPPA devoid of BM and vascular disruption. In this study,
five (13.5%) of 37 eyes with cPPA had focal cPPA that does not
involve the fovea-BMO axis, and their axial length was shorter
than that of the remaining 32 eyes with cPPA involving the
fovea-BMO axis (23.7 vs. 25.5 mm, P ¼ 0.005; independent t-
test). In addition, eyes with focal cPPA in our study have
relatively shorter axial lengths (mean ¼ 23.7 mm) than those
with cPPA in previous studies (mean axial length ranging
between 25.74 and 26.42 mm).6,9,10 It is interesting that all
eyes with focal cPPA had deep-layer microvasculature dropout.
Given that axial growth of the globe leads to the temporal
dragging of the ONH,39 it is less likely that cPPA induced by
axial elongation does not involve the fovea-BMO axis, a central
horizontal axis of the ONH. Therefore, focal cPPA not involving
the fovea-BMO axis may reflect a local alteration of the BM and
loss of an adjacent deep-layer microvasculature derived by
mechanisms other than those from axial elongation. However,
the role of focal cPPA and its relationship with the deep-layer
microvasculature disruption in the pathophysiology of glauco-
ma can only be confirmed by future studies with a larger
TABLE 4. Multivariate Logistic Regression Testing the Association Between the Parapapillary Deep-Layer Microvasculature Dropout and the
Presence of bPPA Devoid of the BM (cPPA) (n¼ 74)
Variables
Multivariate Model 1
With VF MD, AXL,
and CT Included
Multivariate Model 2
With Focal LC Defect,
AXL, and CT Included
Multivariate Model
3 With cpVD, AXL,
and CT Included
Odds Ratio,
95% CI P Value
Odds Ratio,
95% CI P Value
Odds Ratio,
95% CI P Value
cPPA, presence 5.34, 1.46–19.57 0.012 3.75, 1.14–12.33 0.030 5.67, 1.53–20.98 0.009
AXL, per 1 mm longer 1.04, 0.61–1.80 0.877 1.17, 0.70–1.94 0.544 1.09, 0.64–1.85 0.752
CT, per 1 lm thinner 1.01, 1.00–1.02 0.175 1.01, 1.00–1.02 0.228 1.01, 1.00–1.02 0.218
VF MD, per 1 dB worse 1.28, 1.10–1.49 0.001
Focal LC defect, presence 3.67, 1.23–10.96 0.020
cpVD, per 1% lower 1.20, 1.08–1.35 0.001
Statistically significant values are shown in bold. AXL, axial length; CT, total choroidal thickness.
TABLE 3. Univariate Logistic Regression Evaluating Factors Associated
With the Presence of Parapapillary Deep-Layer Microvasculature
Dropout (n ¼ 74)
Variables
Univariate Model
Odds Ratio,
95% CI
P
Value
Age, per 1 y older 1.02, 0.98–1.06 0.418
Female vs. male 2.17, 0.84–5.58 0.106
Non-white race vs. white 1.33, 0.49–3.65 0.577
CCT, per 1 lm thinner 1.01, 1.00–1.02 0.260
IOP, per 1 mm Hg lower 1.09, 0.98–1.20 0.109
Systolic BP, per 1 mm Hg higher 1.00, 0.97–1.04 0.782
Diastolic BP, per 1 mm Hg lower 1.04, 0.99–1.09 0.113
MOPP, per 1 mm Hg higher 1.02, 0.98–1.06 0.375
Diabetes, absence 1.50, 0.19–0.20 0.695
Hypertension, absence 1.21, 0.47–3.12 0.687
DH, absence 1.06, 0.30–3.71 0.931
Circumpapillary vessel density,
per 1% lower
1.16, 1.05–1.28 <0.001
VF MD, per 1 dB worse 1.24, 1.09–1.42 <0.001
Focal LC defect, detection 3.18, 1.22–8.39 0.017
Total choroidal thickness,
per 1 lm thinner
1.01, 1.00–1.02 0.025
Axial length, per 1 mm longer 1.49, 1.00–2.21 0.036
BMO opening area, per 1
mm2 larger
1.53, 0.54–4.29 0.421
Fovea-BMO angle 0.99, 0.89–1.11 0.898
bPPA width, per 1 lm larger 1.01, 1.00–1.01 <0.001
bPPAþBM width, per 1lm larger 1.00, 1.00–1.00 0.714
cPPA, presence 4.08, 1.51–11.03 0.004
cPPA width, per 1 lm larger 1.01, 1.00–1.01 0.005
Statistically significant values are shown in bold. bPPAþBM, cPPA.
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number of study subjects with focal cPPA. Further longitudinal
studies with larger numbers of normal and glaucomatous eyes
with high myopia are required to determine whether the rate
of glaucoma progression differs according to the axial length,
type of cPPA, and the presence of deep-layer microvasculature
dropout.
The current finding that bPPA width was associated with
the deep-layer microvasculature dropout in univariable regres-
sion analysis, but not in multivariable regression analysis,
concurs with our previous results.12 Furthermore, bPPAþBM
width was not associated with dropout in univariable
regression analysis. However, these results do not correspond
with previous histologic studies showing that age-related
atrophy of the RPE-BM complex, known to be a main
mechanism of the bPPAþBM, was associated with the complete
loss of adjacent choriocapillaris.3,40 Differences across the
studies may be related to differences in study design. The
present study utilized an in vivo imaging device, whereas
previous studies used histopathologic analysis. Technical limits
of the current OCT-A device and qualitative analysis of the
deep-layer microvasculature dropout may also hinder detection
of the subtle loss of parapapillary deep-layer microvasculature
in this study.12 Further improvement of the OCT-A technique
and quantitative analysis of the deep-layer microvasculature is
needed.
Despite controversy over the relationship between the
choroidal thickness and deep-layer microvasculature drop-
out,12,17 the current result concurs with a recently published
study that choroidal thickness is not related to the presence of
the deep-layer microvasculature dropout.17 Considering their
topographical relationship, it will be important to investigate
the association between the parapapillary deep-layer micro-
vasculature and the adjacent choroidal structure outside the
PPA.
The present study has several limitations. First, eyes with
and without cPPA were matched by the severity of glaucoma to
minimize the possibility of selection bias that more severe
glaucoma eyes are more likely to have deep-layer microvascu-
lature dropout. Therefore, caution is needed in interpreting the
study results that cPPA was associated with microvasculature
dropout. However, matching did have an advantage as it made
for a more controlled experiment since both deep-layer
microvasculature dropout and presence of the cPPA were
known to be associated with the glaucomatous severity.9–12
Future studies with larger numbers of glaucomatous eyes with
typical cPPA completely devoid of BM are warranted. Second,
as three devices were used for determining the presence of
cPPA in this study, variability of registration across images may
have reduced the strength of the associations. Spectralis SD-
OCT and SS-OCT, instruments that enabled good visualization
of the deeper layers, were utilized to visualize the RPE and
BMO tips, choroidal tissue, and presence of focal LC defects,
whereas Avanti OCT-A was utilized to assess deep-layer
microvasculature.12 However, the three devices were aligned
by using large retinal vessels for determining the location of
dropout within the cPPA, thereby reducing the likelihood of
large misalignment between images.16 Third, it is still unclear
whether optic disc margin based on the infrared fundus image
may reflect an anatomically correct structure, since disc
margin does not uniformly correspond to the BMO-based disc
margin of SD-OCT images.6,9,19,20,41 This may limit an accurate
determination of the RPE and BM and thus may lead to a
variation in the measurement of the bPPA, cPPA, and bPPAþBM
width. However, interobserver agreement for measurement of
TABLE 6. Multivariate Logistic Regression Testing the Association Between the Parapapillary Deep-Layer Microvasculature Dropout and bPPA Width
(n¼ 74)
Variables
Multivariate Model 1
With VF MD, AXL,
and CT included
Multivariate Model 2
With Focal LC Defect,
AXL, and CT Included
Multivariate Model 3 With
cpVD, AXL, and CT Included
Odds Ratio,
95% CI P Value
Odds Ratio,
95% CI P Value
Odds Ratio,
95% CI P Value
bPPA width, per 1 mm larger 1.00, 1.00–1.01 0.176 1.00, 1.00–1.01 0.112 1.00, 1.00–1.01 0.166
AXL, per 1 mm longer 1.25, 0.76–2.03 0.380 1.27, 0.79–2.06 0.323 1.28, 0.78–2.10 0.323
CT, per 1 lm thinner 1.01, 1.00–1.02 0.212 1.01, 1.00–1.02 0.313 1.01, 1.00–1.02 0.233
VF MD, per 1 dB worse 1.24, 1.08–1.43 0.002
Focal LC defect, presence 3.15, 1.09–9.05 0.033
cpVD, per 1% lower 1.16, 1.04–1.29 0.006
Statistically significant values are shown in bold.
TABLE 5. Multivariate Logistic Regression Testing the Association Between the Parapapillary Deep-Layer Microvasculature Dropout and the Width
of bPPA Devoid of the BM (cPPA) (n¼ 74)
Variables
Multivariate Model 1 With
VF MD, AXL, and CT Included
Multivariate Model 2
With Focal LC Defect,
AXL, and CT Included
Multivariate Model 3 With cpVD,
AXL, and CT Included
Odds Ratio,
95% CI P Value
Odds Ratio,
95% CI P Value
Odds Ratio,
95%CI P Value
cPPA width, 1 lm larger 1.01, 1.00–1.01 0.039 1.01, 1.00–1.01 0.073 1.01, 1.00–1.01 0.048
AXL, per 1 mm longer 0.97, 0.55–1.72 0.923 1.10, 0.64–1.88 0.741 1.04, 0.55–1.67 0.878
CT, per 1 lm thinner 1.01, 1.00–1.02 0.150 1.01, 1.00–1.02 0.202 1.01, 1.00–1.02 0.154
VF MD, per 1 dB worse 1.29, 1.10–1.49 0.002
Focal LC defect, presence 3.34, 1.15–9.73 0.027
cpVD, per 1% lower 1.18, 1.06–1.32 0.003
Statistically significant values are shown in bold.
Deep-Layer Microvasculature Dropout and PPA IOVS j April 2018 j Vol. 59 j No. 5 j 2003
the bPPA and cPPA width was good (Fig. 2), and adjunct usage
of the infrared fundus images synchronous to the SD-OCT also
helped to accurately determine the RPE and BMO tips.
In conclusion, parapapillary deep-layer microvasculature
dropout was significantly associated with the presence and
larger width of the bPPA without BM (cPPA) in glaucomatous
eyes, but not with the width of bPPA with intact BM. These
findings suggest that the increased strain and stress on the
exposed scleral flange without BM rather than atrophic change
of the RPE may be associated with the complete loss of
parapapillary deep-layer microvasculature. How this relation-
ship between the mechanical and vascular parameters of the
ONH affects the pathophysiology of the development and
progression of glaucoma remains to be elucidated.
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